Abstract:Background: Sirtuin3 (SIRT3), a pivotal mitochondrial regulatory enzyme, protects cellular components in the central nervous system against oxidative and metabolic stress. However, its influence on cognitive functions, especially within the hippocampal neurons and the cognitive disruptions induced by sepsis, remains elusive. This study aimed to elucidate the direct impact of SIRT3 on neuronal health and its involvement in cognitive deficits following sepsis. Methods: Behavioral changes were evaluated using fear conditioning protocols in wild-type (WT) and SIRT3 deficient (Sirt3(-/-)) mouse models. SIRT3 expression levels were quantified in septic mice following intraperitoneal lipopolysaccharide (LPS) administration (LPS, 10 mg/kg). In cellular experiments, HT22 neuronal cells were exposed to LPS (1 mu g/mL) or conditioned media from LPS-stimulated BV2 microglial cells (Mi-sup). Western blot analysis was employed to assess the presence of synapse-related and mitochondrial apoptosis-associated proteins. Oxidative stress and mitochondrial membrane potential (MMP) were respectively performed with reactive oxygen species (ROS) staining and 5,5 ',6,6 '-tetrachloro1,1 ',3,3 '-tetraethylbenzimid azolocarbocyanine iodide (JC-1) staining. Mitochondrial p66Shc and c-Jun N-terminal kinase (JNK) phosphorylation levels were evaluated through western blotting and immunofluorescence assays. Results: Contextual and cued freezing durations were significantly shorter in Sirt3(-/-) mice than in wild-type counterparts (p < 0.05 and p < 0.01, respectively). Sirt3(-/-) mice exhibited a reduction in postsynaptic density protein 95 (PSD95) (p < 0.05) and an increase in brain-derived neurotrophic factor precursor (pro-BDNF) (p < 0.001). Sepsis led to a marked decrease in SIRT3 expression (p < 0.001) in mice. In cellular studies, the elevation of SIRT3 significantly increased PSD95 (p < 0.01), reduced pro-BDNF (p < 0.05), and enhanced the B-cell lymphoma 2/Bcl-2-associated X protein (Bcl-2/Bax) ratio (p < 0.05) while decreased cytochrome C release (p < 0.05) in Mi-sup-treated HT22 cells. Additionally, SIRT3 elevation reduced ROS production (p < 0.05) and enhanced MMP (p < 0.05). Mi-sup exposure was associated with elevated p-p66Shc/p66Shc and p-JNK/JNK ratio (p < 0.05 and p < 0.01). The activation of JNK/p66Shc was mitigated by either SIRT3 overexpression or the application of a JNK inhibitor (p < 0.01). Conclusion: SIRT3 deficiency contributes to cognitive impairment. SIRT3 expression was reduced in the hippocampus of septic mice, resulting in similar cognitive deficits. Mechanistically, the neuronal JNK/p66Shc activation contributed to SIRT3 deficiency-mediated synaptic dysfunction and mitochondrial apoptosis in response to microglia activation-induced inflammation and oxidative stress. Our findings provide new insights into the role of SIRT3 in cognitive function and its potential clinical significance in sepsis-induced cognitive impairment.

3-Methyladenine attenuates neuroinflammation and improves cognitive function in sepsis-associated encephalopathy by inhibiting autophagy

SIRT3 Protects Against Cognitive Dysfunction Induced by Sepsis-Associated Encephalopathy Via JNK/p66Shc-Regulated Mitochondrial Apoptosis in Mice

CD137L Inhibition Ameliorates Hippocampal Neuroinflammation and Behavioral Deficits in a Mouse Model of Sepsis-Associated Encephalopathy

[Resveratrol attenuates neuroinflammation and alleviates emotional dysfunction in mice with sepsis-associated encephalopathy through promoting chaperone-mediated autophagy (CMA)]

Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) Mitigates Neuroinflammation and Cognitive Impairment by Modulating Glial Activation in Sepsis-Associated Encephalopathy

Electroacupuncture Alleviates Neuroinflammation by Inhibiting the HMGB1 Signaling Pathway in Rats with Sepsis-Associated Encephalopathy

Short Chain Fatty Acids Protect the Cognitive Function of Sepsis Associated Encephalopathy Mice via GPR43

NU9056, a KAT 5 Inhibitor, Treatment Alleviates Brain Dysfunction by Inhibiting NLRP3 Inflammasome Activation, Affecting Gut Microbiota, and Derived Metabolites in LPS-Treated Mice

Resveratrol glycoside mediates microglial endoplasmic reticulum stress to mitigate LPS-induced sepsis-associated cognitive dysfunction

Small Dose of L-dopa/Benserazide Hydrochloride Improved Sepsis-Induced Neuroinflammation and Long-Term Cognitive Dysfunction in Sepsis Mice

β-patchoulene alleviates cognitive dysfunction in a mouse model of sepsis associated encephalopathy by inhibition of microglia activation through Sirt1/Nrf2 signaling pathway

Mitochondria-Targeted Peptide Reverses Mitochondrial Dysfunction and Cognitive Deficits in Sepsis-Associated Encephalopathy

The Neuroprotective Effect of Short Chain Fatty Acids Against Sepsis-Associated Encephalopathy in Mice

The modulatory effects of gut microbes and metabolites on blood–brain barrier integrity and brain function in sepsis-associated encephalopathy

Dichloroacetate attenuates brain injury through inhibiting neuroinflammation and mitochondrial fission in a rat model of sepsis-associated encephalopathy

Integrated transcriptomics and metabolomics analysis of the hippocampus reveals altered neuroinflammation, downregulated metabolism and synapse in sepsis-associated encephalopathy

Neuronal SIRT3 Decline Mediates Sepsis-Associated Encephalopathy Through Microglia Activation

CXCR5 down-regulation alleviates cognitive dysfunction in a mouse model of sepsis-associated encephalopathy: potential role of microglial autophagy and the p38MAPK/NF-κB/STAT3 signaling pathway

Maf1 Ameliorates Sepsis-Associated Encephalopathy by Suppressing the NF-kB/NLRP3 Inflammasome Signaling Pathway

Hydrogen gas alleviates sepsis-induced neuroinflammation and cognitive impairment through regulation of DNMT1 and DNMT3a-mediated BDNF promoter IV methylation in mice

Americanin B inhibits pyroptosis in lipopolysaccharide-induced septic encephalopathy mice through targeting NLRP3 protein